Literature DB >> 23991659

Dabigatran and mechanical heart valves--not as easy as we hoped.

Elaine M Hylek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23991659     DOI： 10.1056/NEJMe1310399

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

2.  [Re-allign (randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran ftexilate in patients after heart valve replacement)].

Authors:  T Zeus; S Nitschmann; M Kelm
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

3.  Dabigatran for mechanical valves.

Authors:  Patricia A Howard
Journal:  Hosp Pharm       Date:  2014-04

Review 4.  Future prospects for contact factors as therapeutic targets.

Authors:  David Gailani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 5.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

Review 6.  Role of novel anticoagulants for patients with mechanical heart valves.

Authors:  Peter Forsberg; Maria T DeSancho
Journal:  Curr Atheroscler Rep       Date:  2014-11       Impact factor: 5.113

Review 7.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.